Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET Notified -
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome Notified -
Univar Solutions Publishes 2025 Sustainability Report and Launches New 2030 Sustainability Goals Notified -
World Finance Awards 2026 Affirm Trusted, Reliable FX and CFD Trading for Clients Worldwide Notified -
General Fusion Achieves Compressional Plasma Heating with LM26 Magnetized Target Fusion Machine Notified -